| Literature DB >> 35959048 |
Fengjuan Ren1, Dan Ruan1, Weilin Hu1, Yan Xiong1, Yuwan Wu1, Siyu Huang1.
Abstract
Objectives: As the largest cohort of healthcare workers and nurses can practice as psychotherapists to integrate the psychotherapeutic interventions as part of routine care. The present study aims to evaluate the effectiveness of supportive psychotherapy (SPT) on patients who had been scheduled to undergo a fiberoptic bronchoscopy (FOB) procedure.Entities:
Keywords: anxiety; depression; fiberoptic bronchoscope; mental health; satisfaction; supportive psychotherapy
Year: 2022 PMID: 35959048 PMCID: PMC9358213 DOI: 10.3389/fpsyg.2022.960049
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
The demographic profile of the two groups.
|
|
|
| ||
|---|---|---|---|---|
| Gender | ||||
| Male | 21 | 25 | ||
| Female | 26 | 20 | 1.807 | 0.297 |
| Age (years) | 49.79 ± 12.20 | 48.47 ± 12.39 | 0.515 | 0.608 |
| Weight (kg) | 65.50 ± 10.17 | 65.69 ± 10.32 | 0.090 | 0.928 |
| ASA status | ||||
| I | 31 | 25 | ||
| II | 16 | 20 | 1.044 | 0.307 |
| Mallampati | ||||
| I | 29 | 24 | ||
| II | 18 | 21 | 0.659 | 0.417 |
SPT, Supportive psychotherapy; ASA, American Society of Anesthesiologists.
Comparison of the depressive and anxious symptoms in patients undergoing fiberoptic bronchoscope (FOB).
|
|
|
| ||
|---|---|---|---|---|
| PHQ-9 score | ||||
| Baseline | 4.98 ± 2.92 | 5.64 ± 2.72 | 1.129 | 0.262 |
| After intervention | 3.43 ± 1.69 | 6.40 ± 2.91 | 6.025 | <0.001 |
| t | 3.154 | 1.272 | ||
|
| 0.002 | 0.207 | ||
| HADS-D score | ||||
| Baseline | 3.91 ± 2.95 | 4.11 ± 3.20 | 0.306 | 0.760 |
| After intervention | 3.04 ± 2.30 | 4.87 ± 3.88 | 3.566 | 0.001 |
| t | 2.563 | 1.007 | ||
|
| 0.012 | 0.317 | ||
| HADS-A score | ||||
| Baseline | 4.21 ± 3.06 | 4.64 ± 2.68 | 0.718 | 0.475 |
| After intervention | 2.66 ± 2.37 | 5.00 ± 3.06 | 4.111 | <0.001 |
| t | 2.748 | 0.586 | ||
|
| 0.007 | 0.559 |
SPT, Supportive psychotherapy; PHQ-9, Patient Health Questionnaire-9; HADS-D, Depression subscale of the Hospital Anxiety and Depression Scale; HADS-A, Anxiety subscale of the Hospital Anxiety and Depression Scale.
Figure 1The reduced depressive and anxiety symptoms in patients undergoing fiberoptic bronchoscope (FOB) after supportive psychotherapy (SPT). The depressive symptoms were evaluated by the Patient Health Questionnaire-9 (PHQ-9) score (A) and Depression subscale of the Hospital Anxiety and Depression Scale (HADS-D) score (B), and the anxious status was evaluated by the Anxiety subscale of the HADS-A score (C).
The number of patients had different degree of anxiety and depression.
|
|
| |||
|---|---|---|---|---|
|
|
|
|
| |
| HADS-D | ||||
| Baseline | 40 | 7 | 33 | 12 |
| After intervention | 47 | 0 | 30 | 15 |
| HADS-A | ||||
| Baseline | 38 | 9 | 37 | 8 |
| After intervention | 47 | 0 | 33 | 12 |
HADS-D, Depression subscale of the Hospital Anxiety and Depression Scale; HADS-A, Anxiety subscale of the Hospital Anxiety and Depression Scale.
Comparison of the health-related quality of life (HRQoL) using SF-36 in patients undergoing FOB.
|
|
|
|
| |
|---|---|---|---|---|
| Physical function | ||||
| Baseline | 62.49 ± 4.90 | 62.80 ± 4.30 | 0.323 | 0.748 |
| After intervention | 69.60 ± 5.08 | 65.07 ± 4.62 | 4.468 | <0.001 |
| t | 6.906 | 2.408 | ||
|
| <0.001 | 0.018 | ||
| Global health | ||||
| Baseline | 62.02 ± 7.79 | 61.49 ± 8.38 | 0.316 | 0.753 |
| After intervention | 72.17 ± 8.95 | 63.40 ± 8.35 | 4.853 | <0.001 |
| t | 5.863 | 1.084 | ||
|
| <0.001 | 0.282 | ||
| Role physical | ||||
| Baseline | 65.81 ± 4.67 | 66.04 ± 4.79 | 0.239 | 0.811 |
| After intervention | 67.89 ± 4.71 | 67.47 ± 4.80 | 0.431 | 0.668 |
| t | 2.156 | 1.408 | ||
|
| 0.034 | 0.163 | ||
| Bodily pain | ||||
| Baseline | 68.49 ± 6.71 | 67.56 ± 6.25 | 0.690 | 0.492 |
| After intervention | 70.43 ± 6.88 | 68.76 ± 6.49 | 1.197 | 0.235 |
| t | 1.381 | 0.894 | ||
|
| 0.171 | 0.374 | ||
| Social function | ||||
| Baseline | 66.47 ± 5.32 | 67.62 ± 5.48 | 1.025 | 0.308 |
| After intervention | 76.40 ± 5.97 | 69.51 ± 5.45 | 5.774 | <0.001 |
| t | 8.516 | 1.639 | ||
|
| <0.001 | 0.105 | ||
| Vitality | ||||
| Baseline | 66.87 ± 7.66 | 68.51 ± 7.46 | 1.038 | 0.302 |
| After intervention | 74.74 ± 7.80 | 70.84 ± 7.61 | 2.426 | 0.017 |
| t | 4.935 | 1.469 | ||
|
| <0.001 | 0.146 | ||
| Role emotional | ||||
| Baseline | 68.30 ± 7.31 | 67.93 ± 7.52 | 0.235 | 0.814 |
| After intervention | 70.38 ± 7.30 | 69.07 ± 7.57 | 0.849 | 0.398 |
| t | 1.383 | 0.712 | ||
|
| 0.170 | 0.478 | ||
| Mental health | ||||
| Baseline | 50.30 ± 6.79 | 48.67 ± 5.97 | 1.221 | 0.225 |
| After intervention | 59.00 ± 6.87 | 47.29 ± 7.06 | 8.063 | <0.001 |
| t | 6.173 | 0.999 | ||
|
| <0.001 | 0.320 |
SPT, Supportive psychotherapy; SF-36, 36-Item Short Form Health Survey questionnaire; FOB, Fiberoptic bronchoscope.
Figure 2The alleviated improved health-related quality of life (HRQoL) in patients undergoing FOB after SPT.
Figure 3The percentages of completely dissatisfied, dissatisfied, partially satisfied, satisfied, and completely satisfied in the intervention and usual-care groups.